Over the past 25 years, due to cost pressures and the development of skills in the Asia-Pacific region (China and India), a large part of the pharmaceutical value chain has been outsourced. The world of APIs / CDMOs serving the pharmaceutical industry is acutely aware of its role in the continuity of drug supply to the patient. The awareness of its social responsibility towards the patient, beyond its direct customers, reinforces the absolute necessity of a robust supply chain. WuXi STA’s Anming Liu, Ph.D. VP of Technical Operations discusses the strategies and best practices WuXi STA has adopted to bolster our supply chain security to the benefit of our customers.
Privacy Overview
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.